These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25467076)

  • 21. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.
    Liu CC; Liang KY; Liao SC
    J Psychopharmacol; 2009 Mar; 23(2):220-2. PubMed ID: 18515466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 24. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication-Induced Weight Change Across Common Antidepressant Treatments : A Target Trial Emulation Study.
    Petimar J; Young JG; Yu H; Rifas-Shiman SL; Daley MF; Heerman WJ; Janicke DM; Jones WS; Lewis KH; Lin PD; Prentice C; Merriman JW; Toh S; Block JP
    Ann Intern Med; 2024 Aug; 177(8):993-1003. PubMed ID: 38950403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
    Seo HJ; Jung YE; Woo YS; Jun TY; Chae JH; Bahk WM
    Hum Psychopharmacol; 2009 Mar; 24(2):135-43. PubMed ID: 19156709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
    Alfaro CL; Lam YW; Simpson J; Ereshefsky L
    J Clin Pharmacol; 2000 Jan; 40(1):58-66. PubMed ID: 10631623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature.
    De Berardis D; Conti CM; Serroni N; Moschetta FS; Olivieri L; Carano A; Salerno RM; Cavuto M; Farina B; Alessandrini M; Janiri L; Pozzi G; Di Giannantonio M
    Int J Immunopathol Pharmacol; 2010; 23(2):417-22. PubMed ID: 20646337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing a new generation of antidepressant drugs.
    Pinder RM
    Acta Psychiatr Scand Suppl; 1997; 391():7-13. PubMed ID: 9265946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
    Schilling C; Gilles M; Blum WF; Daseking E; Colla M; Weber-Hamann B; Lederbogen F; Krumm B; Heuser I; Wudy SA; Kopf D; Deuschle M
    J Clin Psychopharmacol; 2013 Feb; 33(1):99-103. PubMed ID: 23277262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of acute infections in new users of antidepressants: An observational cohort study.
    Aebi N; Meier CR; Jick SS; Lang U; Spoendlin J
    J Affect Disord; 2024 Jun; 354():152-159. PubMed ID: 38479501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
    Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
    J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine.
    Hirschfeld RM; Vornik LA
    J Clin Psychiatry; 2004; 65 Suppl 4():46-52. PubMed ID: 15046541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.